13篇
您的检索式：作者名="Catenacci DV"
|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Next-generation clinical trials: Novel strategies toaddress the challenge of tumor molecular heterogeneity 显示文摘 | Catenacci DV | 2015 | Mol Oncol2015，9，5： | 1 |
| 2 | Durable complete response of metastatic gastric cancer with anti-Met therapy followed by resistance at recurrence显示文摘 | Catenacci DV Henderson L Xiao SY | 2011 | Cancer discov2011，1，7： | 1 |
| 3 | Myelodysplasic syndromes:a comprehensive review显示文摘 | Catenacci DV Schiller GJ | | 0，，06： | 1 |
| 4 | Gastroesophageal cancer: focus on epidemiology, classi -fication, and staging显示文摘 | Sehdev A Catenacci DV | 2013 | Discov Med2013，16，87： | 1 |
| 5 | Toward personalized treatment of ad- vanced biliary tract cancers 显示文摘 | Geynisman DM Catenacci DV | 2012 | Discov Med2012，14，74： | 1 |
| 6 | RON (MST1R) is a novel prognostic marker and therapeutic target for gastroesophageal adenocarcinoma显示文摘 | Catenacci DV Cervantes G Yala S | 2011 | Cancer Biol Ther2011，12，1： | 1 |
| 7 | Durable com- plete response of metastatic gastric cancer with anti-Met therapy followed by resistance at recurrence 显示文摘 | Catenacci DV Henderson L Xiao SY | 2011 | Cancer Discov2011，1，7： | 1 |
| 8 | Gastroesophageal cancer: focus on epidemiology, classification, and staging显示文摘 | Sehdcv A Catenacci DV | 2013 | Discov Med2013，16，87： | 1 |
| 9 | Gastroesophagea] cancer: focus on epidemiology, classification, and staging 显示文摘 | Sehdev A Catenacci DV | 2013 | Discov Med2013，16，87： | 1 |
| 10 | Molecular profiling of cancer - the future of personalized cancer medicine: a primer on cancer biology and the tools necessary to bring molecular testing to the clinic显示文摘 | Striker T Catenacci DV Seiwert TY | 2011 | Semin Oncol2011，，： | 1 |
| 11 | Phase ]/ study eval- uating 2 dosing schedules of oral foretinib (GSK1363089) , cMET/ VEGFR2 inhibitor, in patients with metastatic gastric cancer 显示文摘 | Shah MA Wainberg ZA Catenacci DV | 2013 | PloS One2013，8，54： | 1 |
| 12 | Phase Ⅱ study evaluating 2 dosing schedules of oral foretinib ( GSK1363089 ) ,eMET/VEGFR2 inhibitor, in patients with metastatic gastric Cancer显示文摘 | Shah MA Wainberg ZA Catenacci DV | 2013 | PLoS One2013，8，54： | 1 |
| 13 | Durable complete response of metastatic gastric Cancer with anti-Met therapy fol- lowed by resistance at recurrence 显示文摘 | Catenacci DV Henderson L Xiao SY | 2011 | Cancer Discov2011，1，7： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员